Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01176253 · ClinicalTrials.gov registry record
Detection of Human Beta Cell Death in Type 1 Diabetes Mellitus (T1DM) by Methylation Specific Polymerase Chain Reaction (PCR)
A clinical trial, sponsored by City of Hope Medical Center.
- Completed
- Registry status
- 6
- Enrollment target
NCT01176253: Completed study, sponsored by City of Hope Medical Center.
NCT01176253 is a clinical trial that has completed, run by City of Hope Medical Center. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01176253 has completed, sponsored by City of Hope Medical Center.
- COMPLETED
- Registry status
- 6 participants
- Enrollment target
Study Summary
To investigate the use of methylation-specific PCR (MSP) assays to detect human beta cell-specific gene methylation patterns in serial blood samples drawn from newly diagnosed Type 1 diabetics.
Interventions
- PROCEDURE Blood draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2009-07 |
| Est. Completion | 2015-04 |
What the finished NCT01176253 record still lists
NCT01176253 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 6 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Blood draw is the first listed.
NCT01176253 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01176253 about?
NCT01176253 is a clinical study titled "Detection of Human Beta Cell Death in Type 1 Diabetes Mellitus (T1DM) by Methylation Specific Polymerase Chain Reaction (PCR)". To investigate the use of methylation-specific PCR (MSP) assays to detect human beta cell-specific gene methylation patterns in serial blood samples drawn from newly diagnosed Type 1 diabetics.
What is the current status of trial NCT01176253?
This trial is currently completed. The enrollment target is 6 participants. The study started on 2009-07. Estimated completion is 2015-04.
What interventions are being tested in trial NCT01176253?
The interventions under investigation include: Blood draw (PROCEDURE).
Who is sponsoring clinical trial NCT01176253?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia